Salpingo-Oophorectomy Procedure
Description, Latest Information and Doctors

Salpingo-Oophorectomy Overview

Save information for later
Sign Up

Learn About Salpingo-Oophorectomy

Who are the top Salpingo-Oophorectomy Local Doctors?
Elite in Salpingo-Oophorectomy
Elite in Salpingo-Oophorectomy
Referral may be required
790 Bay Street, 
Toronto, ON, CA 

Steven Narod practices practicing medicine in Toronto, Canada. Mr. Narod is rated as an Elite expert by MediFind in Oophorectomy. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Breast Cancer, BRCA Positive Breast Cancer, Oophorectomy, and Mastectomy.

Elite in Salpingo-Oophorectomy
Elite in Salpingo-Oophorectomy
Referral may be required
76 Grenville St, 
Toronto, ON, CA 

Joanne Kotsopoulos practices practicing medicine in Toronto, Canada. Ms. Kotsopoulos is rated as an Elite expert by MediFind in Oophorectomy. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, BRCA Positive Breast Cancer, Breast Cancer, Oophorectomy, and Salpingo-Oophorectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Salpingo-Oophorectomy
Elite in Salpingo-Oophorectomy
Referral may be required
Montreal, QC, CA 

William Foulkes practices practicing medicine in Montreal, Canada. Mr. Foulkes is rated as an Elite expert by MediFind in Oophorectomy. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Sertoli-Leydig Cell Tumor, Ovarian Cancer, DICER1 Syndrome, Oophorectomy, and Mastectomy.

What are the latest Salpingo-Oophorectomy Clinical Trials?
Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Colon Cancer: A Phase III Multi-arm, Randomized and Controlled Clinical Trial (FOXHIPECT4)

Summary: The main objective of this randomized and controlled trial is to determine whether the use of a proactive strategy, systemic neoadjuvant treatment (FOLFOX) with or without hyperthermic intraperitoneal chemoterapy (HIPEC) with mitomycin C followed by postoperative systemic adjuvant treatment, increases disease-free survival at 36 months in patients with locally advanced colon cancer compared to sta...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)

Summary: This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (...